Clinical Trial Update: Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystrophy) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating theophylline as a treatment for children with pseudohypoparathyroidism type 1a (Albright hereditary osteodystrophy); results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Albright Hereditary Osteodystrophy
• Pseudohypoparathyroidism Type 1a

Drugs mentioned

• Theophylline (Theophylline)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Pseudohypoparathyroidism Type 1a, Albright Hereditary Osteodystrophy | Phase 2 | Status: COMPLETED | Results posted: 2017-05-30